Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients

J Infect. 2023 Aug;87(2):148-150. doi: 10.1016/j.jinf.2023.03.026. Epub 2023 Apr 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Hospitalization
  • Humans
  • SARS-CoV-2
  • Troponin

Substances

  • Troponin
  • nirmatrelvir and ritonavir drug combination